Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia

Alzheimer’s & Dementia: Translational Research & Clinical Interventions · Published 2026-07-01 · DOI 10.1002/trc2.70300

Free full text

Authors (8)

Geon Ha Kim, Hai‐Jeon Yoon, Eun Hee Kim, Ji‐Young Kim, Jiyoung Yeom, Seo Young Kang, Boeun Lee, Jee Hyang Jeong

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Kim, G., Yoon, H., Kim, E., et al. (2026). Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.70300

Related articles